Perez T, Farre J M, Gosset P, Wallaert B, Duquesnoy B, Voisin C, Delcambre B, Tonnel A B
Département de Pneumologie, Hôpital A. Calmette et Institut Pasteur, Lille, France.
Eur Respir J. 1989 Jan;2(1):7-13.
Interstitial lung disease (ILD) can be detected by pulmonary function testing (PFT) in 30-40% of rheumatoid arthritis (RA) patients. We assessed by bronchoalveolar lavage (BAL) the patterns of alveolitis in 21 RA patients: group 1 comprised 12 patients without evidence of ILD, and group 29 patients with clinical ILD defined by abnormal pulmonary function tests and/or chest X-ray. Cellular characteristics of BAL were studied in both groups. In addition, alveolar macrophages (AM) from patients in group 1 were isolated, and three parameters of cellular activation were studied: superoxide anion, fibronectin and neutrophil chemotactic activity generation. Total cell counts were not increased in group 1 but significantly increased in group 2 compared to controls. In group 1, 5/12 patients had elevated lymphocyte percentage (greater than 18%) suggesting subclinical lymphocyte alveolitis. In contrast, neutrophil alveolitis (greater than 4%) was found in 7/9 patients in group 2, mean percentage 12.9 +/- 4.2, compared with 1.2 +/- 6.4% in controls and 1.9 +/- 0.5% in group 1. These changes were not correlated with disease duration nor rheumatoid factor titres. Marked elevation of lymphocyte percentage was observed in patients with abnormal serum beta-2-microglobulin. Alveolar macrophages from group 1 patients released increased amounts of superoxide anion (7260 +/- 2700 vs controls 850 +/- 120 URL/5.10(5) cells), neutrophil chemotactic activity (21 +/- 4.8 vs controls 8.1 +/- 0.7 cells/HPF), and fibronectin (6.1 +/- 1.6 vs controls 1.3 +/- 0.2 ng.10(6) cells/hour). Whether or not lymphocyte alveolitis and/or AM dysfunction are pathogenic mechanisms of subsequent interstitial lung disease in patients who are still free of symptoms remains to be determined.
在30%-40%的类风湿关节炎(RA)患者中,通过肺功能测试(PFT)可检测出间质性肺疾病(ILD)。我们通过支气管肺泡灌洗(BAL)评估了21例RA患者的肺泡炎模式:第1组包括12例无ILD证据的患者,第2组包括9例由异常肺功能测试和/或胸部X线定义的临床ILD患者。对两组患者BAL的细胞特征进行了研究。此外,分离出第1组患者的肺泡巨噬细胞(AM),并研究了细胞活化的三个参数:超氧阴离子、纤连蛋白和中性粒细胞趋化活性生成。第1组的总细胞计数未增加,但与对照组相比,第2组显著增加。在第1组中,5/12例患者淋巴细胞百分比升高(大于18%),提示亚临床淋巴细胞肺泡炎。相比之下,第2组中7/9例患者存在中性粒细胞肺泡炎(大于4%),平均百分比为12.9±4.2,而对照组为1.2±6.4%,第1组为1.9±0.5%。这些变化与疾病持续时间和类风湿因子滴度均无相关性。血清β-2微球蛋白异常的患者观察到淋巴细胞百分比显著升高。第1组患者的肺泡巨噬细胞释放的超氧阴离子量增加(7260±2700对对照组850±120 URL/5×10⁵细胞)、中性粒细胞趋化活性增加(21±4.8对对照组8.1±0.7细胞/HPF)以及纤连蛋白增加(6.1±1.6对对照组1.3±0.2 ng/10⁶细胞/小时)。淋巴细胞肺泡炎和/或AM功能障碍是否为尚无症状患者后续发生间质性肺疾病的致病机制仍有待确定。